Johnson and Johnson (NYSE:JNJ) has announced that the European Commission has approved a supply agreement on behalf of EU members states for the supply of 400 million doses of COVID-19 vaccine. EC to purchase 400 million doses of JNJ’s vaccine According to the Advance...
